【药物名称】
化学结构式(Chemical Structure):
参考文献No.44399
标题:Proteasome inhibitors
作者:Yamaguchi, H.; Kanda, Y.; Ikeda, S.; Akinaga, S.; Yamashita, Y.; Asai, A.; Mizukami, T. (Kyowa Hakko Kogyo Co., Ltd.)
来源:EP 1166781; WO 0043000
合成路线图解说明:

The alkylation of diethyl (R)(+)-2-hydroxysuccinate (I) with 2-methylallyl bromide (II) by means of LiHMDS in THF gives the alkylated diester (III), which is hydrolyzed with KOH in dioxane/water to yield the chiral succinic acid (IV). The regioselective monoesterification of (IV) with benzyl alcohol (V), trifluoroacetic anhydride, TEA and DMAP affords the monobenzyl ester (VI). The lactonization of (VI) by means of bis(2-oxo-3-oxazolidinyl)phosphinic chloride (BOPC) in dichloromethane provides the beta lactone (VII), which is hydrogenolyzed at the benzyl ester group by means of H2 over Pd/C in ethanol to give the carboxylic acid (VIII). Finally this compound is condensed with the dipeptide N2-(tert-butoxycarbonyl-L-alanyl)-N1-(1-naphthylmethyl)-L-lysinamide (IX) by means of DCC and HOBt in dichloromethane to yield the target dipeptide derivative.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us